ActualitésAssisté par IA

Takeda and USAID Partner to Combat Dengue

A dengue prevention program in India by Takeda and USAID, targeting Maharashtra, Odisha, and Uttar Pradesh.

Mrudula Kulkarni
Par Mrudula Kulkarni
Rédacteur en chef - Pharma Now
29 juil. 2024Updated Jun 26, 2025 · 2 min de lecture
Takeda and USAID Partner to Combat Dengue
https://x.com/usaid_india/status/1816789413940068522/photo/3
Journalisme assisté par IA
Reviewed by Mrudula Kulkarni, Rédacteur en chef - Pharma Now

"Haarega Dengue, Haraenge Hum" is the name of a dengue preventive program that has been introduced throughout India by Takeda Biopharmaceuticals India and the United States Agency for International Development (USAID). The program is to encourage individuals to adopt behaviours that might lessen the spread of vector-borne diseases and to teach schools and communities in Maharashtra, Odisha, and Uttar Pradesh about how their actions can help avoid dengue.

The campaign will also look at how infectious disease transmission is impacted by climate change and offer solutions for enhancing readiness and fortifying health systems. General manager of Takeda Biopharmaceuticals India, Annapurna Das, stated that in order to safeguard communities against the effects of vector-borne illnesses, climate change initiatives must be accelerated by all sectors acting boldly and together. The project is in line with Takeda's mission to improve everyone's health and future prospects.

Mrudula Kulkarni
Written by
Mrudula Kulkarni
Rédacteur en chef - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Chargement de la discussion…

Plus dans Pharma News

Tous les articles →